Presented during this week’s American Society of Clinical Oncology’s (ASCO) Annual Meeting, 03 – 07 June 2022, Chicago (IL, USA),…
On the ground at this week’s American Society of Clinical Oncology (ASCO) Annual Meeting, 03 – 07 June 2022, Chicago…
Two studies led by investigators of VHIO’s Thoracic Tumors and Head & Neck Cancer Group, directed by Enriqueta Felip, show…
Cancer is increasingly prevalent in society and the efforts of the research community, doctors and administrations to find solutions to…
Recently, the European Commission launched the Horizon Europe program to promote research and innovation, in order to achieve the United…
Extended follow-up data from the phase III COSMIC-311 study confirm the superior efficacy of multikinase inhibitor cabozantinib in patients with…
Barcelona-based testing service will advance cancer research and enable clinicians to personalize treatments more accurately and quickly for patients with…
We are talking about GEN1046, one of the first bispecific antibodies to be developed and which can join two different…
This year’s Scientific Report: Turning 15 and driving continued, ‘crystalized’ progress against cancer during COVID-19 pandemic waves, celebrates our Institute’s…
An article published recently in A Cancer Journal for Clinicians, which is co-authored by Dr Josep Tabernero, director of the…
In March this year, the U.S. Food and Drug Administration (FDA) released new, nonbinding recommendations for enrolling more elderly patients…
The new antibody, MCLA-158, targets both epidermal growth factor receptor (EGFR) and protein LGR5 and has been shown to be…
